Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Milton

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 24, 2016
Bone Metastases and Skeletal-Related Events in Medullary Thyroid CarcinomaJian Yu Xu, William A Murphy, Denái R Milton, et al.
Transplantation and Cellular Therapy|July 6, 2026
A Simplified Frailty Score Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell TransplantationChelby Wakefield, Curtis Marcoux, Denái R Milton, et al.
Transplantation and Cellular Therapy|July 12, 2023
Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell TransplantationFevzi F Yalniz, Uri Greenbaum, Oren Pasvolsky, et al.
Transplantation and Cellular Therapy|August 8, 2022
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple MyelomaOren Pasvolsky, Denái R Milton, Mikael Rauf, et al.
Bone Marrow Transplantation|October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Transplantation and Cellular Therapy|October 24, 2024
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17pCurtis Marcoux, Oren Pasvolsky, Denái R Milton, et al.
Transplantation and Cellular Therapy|September 6, 2023
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple MyelomaOren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Nature Communications|March 15, 2024
Characterisation of colistin resistance in Gram-negative microbiota of pregnant women and neonates in NigeriaE A R Portal, K Sands, C Farley, et al.
British Journal of Haematology|March 6, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantationKamal Alzahrani, Oren Pasvolsky, Zhongya Wang, et al.
American Journal of Hematology|February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trialIssa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|September 24, 2016
Bone Metastases and Skeletal-Related Events in Medullary Thyroid CarcinomaJian Yu Xu, William A Murphy, Denái R Milton, et al.
Transplantation and Cellular Therapy|July 6, 2026
A Simplified Frailty Score Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell TransplantationChelby Wakefield, Curtis Marcoux, Denái R Milton, et al.
Transplantation and Cellular Therapy|July 12, 2023
Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell TransplantationFevzi F Yalniz, Uri Greenbaum, Oren Pasvolsky, et al.
Transplantation and Cellular Therapy|August 8, 2022
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple MyelomaOren Pasvolsky, Denái R Milton, Mikael Rauf, et al.
Bone Marrow Transplantation|October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Transplantation and Cellular Therapy|October 24, 2024
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17pCurtis Marcoux, Oren Pasvolsky, Denái R Milton, et al.
Transplantation and Cellular Therapy|September 6, 2023
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple MyelomaOren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Nature Communications|March 15, 2024
Characterisation of colistin resistance in Gram-negative microbiota of pregnant women and neonates in NigeriaE A R Portal, K Sands, C Farley, et al.
British Journal of Haematology|March 6, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantationKamal Alzahrani, Oren Pasvolsky, Zhongya Wang, et al.
American Journal of Hematology|February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trialIssa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Pageof 19